OncoRes Medical

OncoRes Medical is a medical device company based in Perth, established in 2016. The company specializes in innovative intraoperative imaging technology designed to enhance cancer surgery outcomes, particularly in Breast Conserving Surgery (BCS) for breast cancer. They have developed a handheld imaging probe that utilizes optical coherence tomography (OCT) and elastography, known as Quantitative Micro Elastography (QME) or Optical Coherence Micro-Elastography (OCME). This technology provides surgeons with real-time, high-resolution assessments of tissue microstructure during surgery. The imaging probe allows for precise differentiation between cancerous and healthy tissue by measuring tissue stiffness at a microscopic level. This capability helps surgeons identify residual cancer cells during procedures, significantly reducing the need for repeat operations. OncoRes Medical collaborates with leading researchers and clinicians, including institutions like the University of Western Australia and the Harry Perkins Institute of Medical Research. Their work is supported by the Australian Government’s BioMedTech Horizons program and the Medical Research Commercialisation Fund, highlighting their commitment to advancing health technologies.

• Employees 41
• Founded 2016
• Total Funding $21489601